| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Examines kidney function, fluid and electrolyte balance, acid–base regulation, filtration–reabsorption–secretion processes, osmotic control, blood-volume maintenance, and systemic homeostasis. Includes nephron transport physiology, hormonal regulation (RAAS, ADH, ANP), and whole-body fluid distribution. Excludes cellular-level transporter biochemistry and cardiovascular/respiratory homeostasis except when they directly mediate renal–fluid control. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates from nephron-level processes (µm–mm) through organ-level control (kidney, vasculature) to whole-body homeostasis, across timescales from seconds (ion-channel changes) to hours/days (fluid regulation, acid–base compensation). |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Nephrons, glomeruli, tubules, transporters, channels, pumps, filtrate, interstitial fluid, blood plasma, electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻), hormones (RAAS, ADH, ANP), and acid–base buffers. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Filtration rate, reabsorption fraction, secretion rate, osmolarity, pH, electrolyte concentration, fluid volume, oncotic pressure, hydrostatic pressure, and permeability. |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Filtration vs reabsorption vs secretion, cortical vs juxtamedullary nephrons, intracellular vs extracellular fluid compartments, electrolyte classes, acid–base disturbances, and regulatory hormone classes. |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | GFR, plasma osmolarity, urine osmolarity, Na⁺/K⁺ concentrations, pH, bicarbonate level, blood volume, urine flow rate, RAAS/ADH activity levels, and ECF/ICF fluid distribution. |
| | Parameterization | How variables encode and represent the system’s state. | State encoded through clearance equations, osmotic gradients, electrolyte panels, acid–base curves, hormonal levels, and compartment-volume estimates. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating nephrons as identical, linearizing reabsorption kinetics, modeling tubules as uniform, assuming constant interstitial gradients, ignoring regional blood-flow variation, or simplifying acid–base buffers to single-compartment systems. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Idealizations fail under extreme fluid loss, severe acidosis/alkalosis, renal pathology, disrupted medullary gradients, hormonal dysregulation, or highly heterogeneous nephron behavior. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Assumes predictable filtration–reabsorption–secretion principles, stable osmotic and hydrostatic laws, reliable hormonal feedback, and continuous compartment-level fluid dynamics. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes electrochemical gradients remain physiologically meaningful, nephrons maintain consistent transport characteristics, fluid compartments behave coherently, and systemic regulation preserves homeostasis. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | Filtration, reabsorption, secretion, electrolyte handling, and acid–base control must align without contradiction across nephron, kidney, and whole-body levels. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Entities (nephrons, electrolytes, hormones), variables (GFR, osmolarity, pH), and assumptions (gradient continuity, feedback control) must integrate into a unified renal–fluid homeostasis framework. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Filtration markers, urine flow, urine osmolarity, electrolyte concentrations, blood pH, bicarbonate levels, plasma osmolarity, blood volume indicators, RAAS/ADH activity markers, and acid–base compensation responses. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Minimum detectable electrolyte change (mEq/L), osmometer sensitivity limits, smallest measurable urine flow rate, lower bounds of pH and bicarbonate precision, and assay limits for renin/aldosterone/ADH measurement. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | mEq/L (electrolytes), mOsm/kg (osmolarity), mL/min (urine flow, clearance), pH units, mmHg (blood pressure contributors), L (fluid volumes), and ng/mL or pg/mL (hormones). |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | Osmometers, electrolyte analyzers, blood-gas analyzers, urine flow meters, clearance-testing systems, hormone immunoassays, metabolic carts, and volume-assessment tools (bioimpedance, dilution methods). |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Definitions for “GFR,” “clearance,” “osmolarity,” “acid–base disturbance,” “ECF/ICF volume,” “urine concentration,” and “renal compensation,” tied to measurable clinical and laboratory criteria. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | Standard procedures including 24-hour urine collection, spot urine electrolyte tests, inulin/creatinine clearance tests, blood-gas sampling, osmolarity measurement workflows, and endocrine (RAAS/ADH) assays. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Serial fluid sampling, timed urine collection, repeated electrolyte panels, acid–base measurement cycles, dynamic water-loading or restriction tests, and orthostatic or volume-challenge protocols. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Selecting time intervals, fluid compartments (blood, urine), hydration states, stress or rest conditions, replicate samples, and controlled intake/excretion windows to ensure representative fluid–homeostasis data. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | Osmolarity tables, electrolyte profiles, pH–bicarbonate curves, clearance graphs, hormone panels, urine-concentration traces, and acid–base diagrams. |
| | Resolution | The granularity or precision with which data is captured. | Highly sensitive electrolyte and pH precision (decimal-level), osmolarity resolution (±1–2 mOsm/kg), urine flow minute-scale resolution, and high precision for hormonal immunoassays. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Calibration of osmometry, electrolyte analyzers, blood-gas machines, clearance instrumentation, bioimpedance tools, and hormone assay standards, including drift correction and reagent verification. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Errors from sample dilution, improper timing, assay cross-reactivity, sensor drift, incomplete urine collection, hydration variability, and biological noise in endocrine fluid-regulation systems. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Core physiological relations including filtration-pressure relationships, Starling forces, clearance laws, osmotic/oncotic gradients, acid–base equilibrium rules, Na⁺/water coupling, and RAAS-mediated volume control. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Stable patterns such as characteristic GFR ranges, conserved osmotic gradients in the nephron, fixed acid–base buffer capacities, predictable electrolyte handling rules (e.g., Na⁺ reabsorption patterns), and consistent ADH sensitivity curves. |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Mechanisms driving homeostasis: filtration at glomeruli, tubular transport, countercurrent multiplication, hormonal feedback (RAAS, ADH, ANP), buffer actions, and renal compensation for respiratory/metabolic disturbances. |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Ordered sequences such as decreased blood volume → renin release → angiotensin II formation → aldosterone release → Na⁺/water retention → restored volume; or pH drop → increased ventilation/renal H⁺ secretion → pH normalization. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Key concepts: GFR, clearance, osmolarity, hydrostatic/oncotic pressure, countercurrent multiplication, electrolyte balance, acid–base balance, ECF/ICF compartments, and homeostatic control. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Nephron segments, transport processes (active/passive), fluid compartments, electrolyte categories, acid–base disorders (metabolic/respiratory acidosis/alkalosis), and hormonal regulatory types (RAAS/ADH/ANP). |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | Starling equation, clearance equations (C = UV/P), Henderson–Hasselbalch equation, osmotic-pressure equations, filtration-pressure formulas, and mass-balance equations for electrolytes and water. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | Multi-compartment fluid models, nephron transport models, acid–base regulation models, RAAS feedback models, countercurrent exchange models, and whole-body homeostasis simulations. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Treating nephrons as identical, assuming perfectly linear transport, reducing countercurrent systems to single gradients, ignoring tubular heterogeneity, or simplifying acid–base buffering to one-compartment models. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Valid in stable hydration states, moderate pH deviations, normal renal function, and intact hormonal control; break down under pathology (renal failure, diabetes, dehydration), extreme disturbances, or disrupted gradient systems. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Integrated fluid balance theory, multi-compartment homeostasis models, RAAS-centered regulation, acid–base compensation theory, and unified renal–respiratory–endocrine control of systemic homeostasis. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Links to cardiovascular physiology, respiratory physiology, endocrinology, metabolism, biochemistry, and systems biology through shared regulation of pressure, fluid volume, electrolytes, and pH. |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Manipulating fluid intake/excretion, altering electrolyte loads (Na⁺, K⁺, water challenges), modifying arterial pressure, altering hormonal states (RAAS/ADH/ANP modulation), and inducing controlled acid–base disturbances to test causality in renal/homeostatic responses. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Monitoring spontaneous changes in urine output, electrolyte balance, osmolarity, pH, blood volume, hormonal activity, and homeostatic responses under natural or minimally disturbed conditions. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Evaluating predictions about filtration, reabsorption, secretion, osmotic gradients, RAAS activity, ADH sensitivity, acid–base correction, or compartment-volume shifts through structured physiological tests. |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Repeating clearance tests, electrolyte panels, urine analyses, pH/bicarbonate measurements, hormone assays, and fluid-regulation trials across multiple subjects or experimental runs to ensure reliability. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Applying regression, clearance-curve fitting, mixed-effects models, acid–base curve analysis, mass-balance calculations, and Bayesian modeling to interpret renal and fluid-regulation datasets. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Comparing nephron-transport models, fluid-compartment models, acid–base regulation models, RAAS feedback frameworks, and integrated homeostasis simulations for predictive accuracy and robustness. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying errors from incomplete urine collection, measurement drift in osmometry/electrolyte assays, sampling timing errors, hormone-assay variability, and biological noise in fluid/hormonal responses. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Controlling intake/excretion timing, standardizing sample handling, calibrating measurement systems, blinding laboratory interpretation, and maintaining consistent hydration and posture across measurements. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Independent review of renal-clearance interpretations, electrolyte-handling claims, RAAS/ADH regulatory modeling, and acid–base compensation analyses through cross-lab replication and critique. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Updating clearance theory, acid–base models, RAAS/ADH frameworks, and fluid-compartment dynamics when new physiological or clinical evidence contradicts classical assumptions. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full reporting of intake/output records, sampling times, assay methods, calibration logs, environmental conditions, and modeling assumptions in renal–homeostatic studies. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Ensuring proper handling of human/animal subjects, minimizing dehydration/overhydration risk, honest reporting of data, and adherence to physiological research and clinical safety standards. |